Janus Henderson Investors US’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$36.2M Buy
651,917
+596
+0.1% +$32.9K 0.03% 506
2016
Q4
$33.9M Sell
651,321
-3,390
-0.5% -$164K 0.03% 515
2016
Q3
$31.6M Sell
654,711
-3,272
-0.5% -$165K 0.03% 519
2016
Q2
$36.5M Buy
657,983
+7,927
+1% +$437K 0.03% 473
2016
Q1
$34.7M Sell
650,056
-7,694
-1% -$379K 0.03% 482
2015
Q4
$33.9M Buy
657,750
+238
+0% +$11.8K 0.03% 520
2015
Q3
$29.7M Sell
657,512
-10,292
-2% -$486K 0.03% 521
2015
Q2
$30.9M Sell
667,804
-9,302
-1% -$407K 0.03% 526
2015
Q1
$29M Buy
677,106
+10,321
+2% +$393K 0.02% 550
2014
Q4
$23.2M Buy
666,785
+4,195
+0.6% +$139K 0.02% 574
2014
Q3
$21.4M Sell
662,590
-501
-0.1% -$16.8K 0.02% 568
2014
Q2
$22.5M Sell
663,091
-16,834
-2% -$539K 0.02% 545
2014
Q1
$18.5M Sell
679,925
-182
-0% -$5.41K 0.02% 570
2013
Q4
$24.3M Buy
680,107
+31,132
+5% +$1.03M 0.02% 509
2013
Q3
$19.5M Buy
648,975
+173,996
+37% +$5.69M 0.02% 535
2013
Q2
$13.8M Buy
+474,979
New +$13.4M 0.01% 567

Other funds holding PBH

Janus Henderson Investors US's PBH Position: Q1 2017 in Review

Janus Henderson Investors US increased its Prestige Consumer Healthcare (PBH) stake by 0.09% in Q1 2017, buying an estimated $32.9K and bringing the position to 651,917 shares worth $36.2M. The position accounts for 0.03% of the portfolio, ranked #506.

Janus Henderson Investors US first reported a position in PBH in Q2 2013 and has held it in 16 quarters since. The position peaked at $36.5M in Q2 2016. 240 funds tracked by Wall St. Rank hold PBH as of Q1 2017.

  • Janus Henderson Investors US held 651,917 shares of Prestige Consumer Healthcare worth $36.2M as of Q1 2017.
  • Janus Henderson Investors US bought 596 Prestige Consumer Healthcare shares in Q1 2017, an estimated $32.9K.
  • Prestige Consumer Healthcare made up 0.03% of Janus Henderson Investors US's portfolio in Q1 2017, its #506 holding.
  • Janus Henderson Investors US first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Prestige Consumer Healthcare position peaked at $36.5M in Q2 2016.
  • 240 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.